Home antibiotic therapy for low-risk cancer patients with fever and neutropenia : a pilot study of 30 patients based on a validated prediction rule.
To assess the feasibility of early discharge to home therapy with standard intravenous antibiotics in 30 patients with fever and neutropenia at low risk by a validated clinical decision rule.
Patients and Methods
Newly admitted outpatients with fever and neutropenia were evaluated for home therapy during 2 days of inpatient observation.
To evaluate enrolled patients' acceptance of home care, we assessed patient attitudes and quality of life before and after home therapy.
To assess economic effects, we compared the medical charges of patients treated at home with those of medically eligible patients who remained in the hospital.
Mots-clés Pascal : Tumeur maligne, Complication, Neutropénie, Fièvre, A domicile, Antibactérien, Chimiothérapie, Antibiotique, Méthode empirique, Voie intraveineuse, Qualité vie, Economie santé, Homme, Hémopathie, Leucopénie, Traitement
Mots-clés Pascal anglais : Malignant tumor, Complication, Neutropenia, Fever, At home, Antibacterial agent, Chemotherapy, Antibiotic, Empirical method, Intravenous administration, Quality of life, Health economy, Human, Hemopathy, Leukopenia, Treatment
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0175385
Code Inist : 002B02S02. Création : 199406.